Return On Assets of Cidara Therapeutics, Inc. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cidara Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • Cidara Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -51%, a 52% increase year-over-year.
  • Cidara Therapeutics, Inc. annual Return On Assets for 2024 was -113%, a 246% decline from 2023.
  • Cidara Therapeutics, Inc. annual Return On Assets for 2023 was -33%, a 49% increase from 2022.
  • Cidara Therapeutics, Inc. annual Return On Assets for 2022 was -64%, a 7.4% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Cidara Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -51% +55% +52% 01 Jul 2025 30 Sep 2025
Q2 2025 -43% +85% +67% 01 Apr 2025 30 Jun 2025
Q1 2025 -99% -41% -71% 01 Jan 2025 31 Mar 2025
Q4 2024 -113% -80% -246% 01 Oct 2024 31 Dec 2024
Q3 2024 -106% -55% -108% 01 Jul 2024 30 Sep 2024
Q2 2024 -127% -112% -746% 01 Apr 2024 30 Jun 2024
Q1 2024 -58% -37% -180% 01 Jan 2024 31 Mar 2024
Q4 2023 -33% +32% +49% 01 Oct 2023 31 Dec 2023
Q3 2023 -51% +11% +18% 01 Jul 2023 30 Sep 2023
Q2 2023 -15% +110% +88% 01 Apr 2023 30 Jun 2023
Q1 2023 -21% +49% +70% 01 Jan 2023 31 Mar 2023
Q4 2022 -64% +5.1% +7.4% 01 Oct 2022 31 Dec 2022
Q3 2022 -62% +20% +25% 01 Jul 2022 30 Sep 2022
Q2 2022 -125% -48% -62% 01 Apr 2022 30 Jun 2022
Q1 2022 -70% +51% +42% 01 Jan 2022 31 Mar 2022
Q4 2021 -69% +33% +32% 01 Oct 2021 31 Dec 2021
Q3 2021 -82% +6.5% +7.3% 01 Jul 2021 30 Sep 2021
Q2 2021 -77% -21% -36% 01 Apr 2021 30 Jun 2021
Q1 2021 -121% -66% -121% 01 Jan 2021 31 Mar 2021
Q4 2020 -102% -41% -66% 01 Oct 2020 31 Dec 2020
Q3 2020 -89% -32% -56% 01 Jul 2020 30 Sep 2020
Q2 2020 -57% +21% +27% 01 Apr 2020 30 Jun 2020
Q1 2020 -55% +14% +20% 01 Jan 2020 31 Mar 2020
Q4 2019 -62% +6% +8.8% 01 Oct 2019 31 Dec 2019
Q3 2019 -57% +12% +17% 01 Jul 2019 30 Sep 2019
Q2 2019 -78% -5.3% -7.3% 01 Apr 2019 30 Jun 2019
Q1 2019 -69% +11% +14% 01 Jan 2019 31 Mar 2019
Q4 2018 -68% +2% +2.8% 01 Oct 2018 31 Dec 2018
Q3 2018 -69% -3.8% -5.8% 01 Jul 2018 30 Sep 2018
Q2 2018 -73% -10% -16% 01 Apr 2018 30 Jun 2018
Q1 2018 -79% -24% -42% 01 Jan 2018 31 Mar 2018
Q4 2017 -70% -19% -37% 01 Oct 2017 31 Dec 2017
Q3 2017 -65% -19% -42% 01 Jul 2017 30 Sep 2017
Q2 2017 -62% -23% -60% 01 Apr 2017 30 Jun 2017
Q1 2017 -56% -24% -78% 01 Jan 2017 31 Mar 2017
Q4 2016 -51% -20% -63% 01 Oct 2016 31 Dec 2016
Q3 2016 -46% -13% -38% 01 Jul 2016 30 Sep 2016
Q2 2016 -39% 01 Apr 2016 30 Jun 2016
Q1 2016 -31% 01 Jan 2016 31 Mar 2016
Q4 2015 -31% 01 Oct 2015 31 Dec 2015
Q3 2015 -33% 01 Jul 2015 30 Sep 2015

Cidara Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -113% -80% -246% 01 Jan 2024 31 Dec 2024
2023 -33% +32% +49% 01 Jan 2023 31 Dec 2023
2022 -64% +5.1% +7.4% 01 Jan 2022 31 Dec 2022
2021 -69% +33% +32% 01 Jan 2021 31 Dec 2021
2020 -102% -41% -66% 01 Jan 2020 31 Dec 2020
2019 -62% +6% +8.8% 01 Jan 2019 31 Dec 2019
2018 -68% +2% +2.8% 01 Jan 2018 31 Dec 2018
2017 -70% -19% -37% 01 Jan 2017 31 Dec 2017
2016 -51% -20% -63% 01 Jan 2016 31 Dec 2016
2015 -31% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.